Trial
NCT00923806
Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Metastatic Cancer
Intervention
PG13-CEA_TCR (Anti-CEA TCR PBL)
Why stopped
Study was terminated due to poor accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-23